Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease.

Shin S, Lee JE, Hong JY, Sunwoo MK, Sohn YH, Lee PH.

J Neurol Neurosurg Psychiatry. 2012 Dec;83(12):1155-61. doi: 10.1136/jnnp-2012-303391. Epub 2012 Aug 29.

PMID:
22933812
2.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M.

Mov Disord. 2012 Mar;27(3):349-56. doi: 10.1002/mds.24893. Epub 2012 Jan 24. Review.

3.

Working memory, long-term memory, and medial temporal lobe function.

Jeneson A, Squire LR.

Learn Mem. 2011 Dec 16;19(1):15-25. doi: 10.1101/lm.024018.111. Print 2012 Jan. Review.

4.

Neurodegeneration across stages of cognitive decline in Parkinson disease.

Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, Wolk DA, Moberg PJ, Xie SX, Clark CM.

Arch Neurol. 2011 Dec;68(12):1562-8. doi: 10.1001/archneurol.2011.725.

5.

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A.

Brain. 2012 Jan;135(Pt 1):170-80. doi: 10.1093/brain/awr277. Epub 2011 Nov 21.

6.

Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness.

Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junqué C, Bargallo N, Tolosa E.

Hum Brain Mapp. 2012 Nov;33(11):2521-34. doi: 10.1002/hbm.21378. Epub 2011 Sep 6.

PMID:
21898679
7.

Grey matter atrophy in cognitively impaired Parkinson's disease.

Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):188-94. doi: 10.1136/jnnp-2011-300828. Epub 2011 Sep 2.

PMID:
21890574
8.

A comparison of voxel and surface based cortical thickness estimation methods.

Clarkson MJ, Cardoso MJ, Ridgway GR, Modat M, Leung KK, Rohrer JD, Fox NC, Ourselin S.

Neuroimage. 2011 Aug 1;57(3):856-65. doi: 10.1016/j.neuroimage.2011.05.053. Epub 2011 May 26.

PMID:
21640841
9.

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

Compta Y, Parkkinen L, O'Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T.

Brain. 2011 May;134(Pt 5):1493-1505. doi: 10.1093/brain/awr031.

10.

Cognitively preserved subjects with transitional cerebrospinal fluid ß-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas.

Fortea J, Sala-Llonch R, Bartrés-Faz D, Lladó A, Solé-Padullés C, Bosch B, Antonell A, Olives J, Sanchez-Valle R, Molinuevo JL, Rami L.

Biol Psychiatry. 2011 Jul 15;70(2):183-90. doi: 10.1016/j.biopsych.2011.02.017. Epub 2011 Apr 23.

PMID:
21514924
11.

A new neural framework for visuospatial processing.

Kravitz DJ, Saleem KS, Baker CI, Mishkin M.

Nat Rev Neurosci. 2011 Apr;12(4):217-30. doi: 10.1038/nrn3008. Review.

12.

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.

Setó-Salvia N, Clarimón J, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Combarros O, Mateo JI, Regaña D, Martínez-Corral M, Marquié M, Alcolea D, Suárez-Calvet M, Molina-Porcel L, Dols O, Gómez-Isla T, Blesa R, Lleó A, Kulisevsky J.

Arch Neurol. 2011 Mar;68(3):359-64. doi: 10.1001/archneurol.2011.17.

PMID:
21403021
13.

The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status.

Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH.

Mov Disord. 2011 Feb 1;26(2):289-96. doi: 10.1002/mds.23477. Epub 2011 Mar 2.

PMID:
21370255
14.

Complexity and coherency: integrating information in the brain.

Tononi G, Edelman GM, Sporns O.

Trends Cogn Sci. 1998 Dec 1;2(12):474-84.

PMID:
21227298
15.

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M.

Neurology. 2010 Sep 21;75(12):1062-9. doi: 10.1212/WNL.0b013e3181f39d0e.

16.

Apolipoprotein E ε4-related thickening of the cerebral cortex modulates selective attention.

Espeseth T, Westlye LT, Walhovd KB, Fjell AM, Endestad T, Rootwelt H, Reinvang I.

Neurobiol Aging. 2012 Feb;33(2):304-322.e1. doi: 10.1016/j.neurobiolaging.2009.12.027. Epub 2010 Apr 10.

PMID:
20382449
17.

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA.

Brain. 2009 Nov;132(Pt 11):2958-69. doi: 10.1093/brain/awp245. Epub 2009 Oct 7.

PMID:
19812213
18.

Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects.

Ferrer I.

Prog Neurobiol. 2009 Jun;88(2):89-103. doi: 10.1016/j.pneurobio.2009.02.004. Epub 2009 Mar 9. Review.

PMID:
19482226
19.

Neurodegenerative diseases target large-scale human brain networks.

Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD.

Neuron. 2009 Apr 16;62(1):42-52. doi: 10.1016/j.neuron.2009.03.024.

20.

Mapping the structural core of human cerebral cortex.

Hagmann P, Cammoun L, Gigandet X, Meuli R, Honey CJ, Wedeen VJ, Sporns O.

PLoS Biol. 2008 Jul 1;6(7):e159. doi: 10.1371/journal.pbio.0060159.

Supplemental Content

Support Center